Solana climbs and XRP ETF talks heat up, but experts say Layer Brett’s $0.0053 presale could explode 13,000% before 2026, making it the best altcoin to buy now.Solana climbs and XRP ETF talks heat up, but experts say Layer Brett’s $0.0053 presale could explode 13,000% before 2026, making it the best altcoin to buy now.

Experts Say Forget Solana, XRP ETF Front Run, This Explosive Altcoin Is Set For 13,000% Gains Before 2026

solana main2 image 20

Crypto traders are raving with excitement, but not about Solana or the long-awaited XRP ETF. Instead, a new altcoin called Layer Brett is stealing the spotlight, with experts boldly predicting jaw-dropping gains of up to 13,000% by 2026. With its presale gaining traction, this new DeFi token could be the next breakout story—and here’s why:

LBRETT May Be Set To Witness Explosive Growth Soon

At first glance, Layer Brett looks like just another meme coin project that could easily be tossed into the same bucket as DOGE or SHIB since it plays off internet humor and community hype. However, when you take a closer look, it quickly becomes clear that this project carries more weight than a typical joke token. This is because behind the memes lies an actual piece of blockchain innovation.

The unique angle with LBRETT is that it isn’t simply trying to ride the popularity wave; instead, it combines the viral energy of meme culture with the scalability of an Ethereum Layer 2 blockchain. While the branding might make you laugh, Layer Brett’s underlying technology is built to handle serious transactions. This combination, coupled with the $2 million revenue from its presale, also gives LBRETT the image of being more than just another flash-in-the-pan experiment.

Moreover, Layer Brett’s roadmap introduces Web3 integrations, NFT utilities, and crypto governance, positioning it as more than just another ERC-20 token. With transparent tokenomics, a capped supply of 10 billion, and a vibrant community, it has the fundamentals to rival other top altcoins while keeping the cultural edge that drives meme adoption.

image 17

SOL Faces Potential Upward Surge

In just a little over a month, SOL has gone up by an impressive 22%, maintaining a trading range around $200 for the past week. This climb isn’t very surprising, especially because it fits the market’s current rhythm. Since April, SOL has inched upward and constantly presses against a resistance point that now has Solana traders watching closely.

The technicals also back this price surge. Solana’s ADX is 28 which is a huge sign of SOL being on a steady trend instead of random price movements. Above 25, the index confirms direction, and at 28, the market seems to be showing its hand. As expected, iInterest around SOL is building. For example, on X, trader Kamran Asghar noted that SOL’s price action looks compressed, coiling tighter each day. He called it a setup worth tracking for a possible breakout.

Is An XRP ETF About To Get Greenlighted?

Amplify ETFs, an Illinois-based firm managing $12.6 billion as of July 31, has filed for a new XRP ETF. However, this one is structured differently from a traditional spot product. While a spot ETF holds the asset itself, the Options Income version relies on strategies like covered calls on XRP. This way, XRP can generate consistent monthly income for investors.

These XRP ETFs typically secure some form of exposure to the underlying asset, then sell call options, and the proceeds are distributed as steady monthly payouts. Although the SEC has yet to approve a spot XRP ETF, prediction markets and XRP analysts remain confident it will happen this year. In fact, many believe Amplify’s XRP filing could be the one that finally breaks through.

Conclusion 

While Solana and XRP ETFs dominate headlines, experts suggest the real opportunity may lie in Layer Brett. With over 5,000 holders and more than $2 million raised in a few weeks, LBRETT could deliver the explosive 13,000% gains to early believers before 2026! 

Can You Afford To Miss LBRETT’s Climb To Crypto Stardom? Secure Your LBRETT Tokens Today!

Presale: Layer Brett | Fast & Rewarding Layer 2 Blockchain

Telegram: Telegram: View @layerbrett

X: (1) Layer Brett (@LayerBrett) / X

image 22

This article is not intended as financial advice. Educational purposes only.

Market Opportunity
XRP Logo
XRP Price(XRP)
$2.0637
$2.0637$2.0637
-1.56%
USD
XRP (XRP) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Over $145M Evaporates In Brutal Long Squeeze

Over $145M Evaporates In Brutal Long Squeeze

The post Over $145M Evaporates In Brutal Long Squeeze appeared on BitcoinEthereumNews.com. Crypto Futures Liquidations: Over $145M Evaporates In Brutal Long Squeeze
Share
BitcoinEthereumNews2026/01/16 11:35
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26
Edges higher ahead of BoC-Fed policy outcome

Edges higher ahead of BoC-Fed policy outcome

The post Edges higher ahead of BoC-Fed policy outcome appeared on BitcoinEthereumNews.com. USD/CAD gains marginally to near 1.3760 ahead of monetary policy announcements by the Fed and the BoC. Both the Fed and the BoC are expected to lower interest rates. USD/CAD forms a Head and Shoulder chart pattern. The USD/CAD pair ticks up to near 1.3760 during the late European session on Wednesday. The Loonie pair gains marginally ahead of monetary policy outcomes by the Bank of Canada (BoC) and the Federal Reserve (Fed) during New York trading hours. Both the BoC and the Fed are expected to cut interest rates amid mounting labor market conditions in their respective economies. Inflationary pressures in the Canadian economy have cooled down, emerging as another reason behind the BoC’s dovish expectations. However, the Fed is expected to start the monetary-easing campaign despite the United States (US) inflation remaining higher. Investors will closely monitor press conferences from both Fed Chair Jerome Powell and BoC Governor Tiff Macklem to get cues about whether there will be more interest rate cuts in the remainder of the year. According to analysts from Barclays, the Fed’s latest median projections for interest rates are likely to call for three interest rate cuts by 2025. Ahead of the Fed’s monetary policy, the US Dollar Index (DXY), which tracks the Greenback’s value against six major currencies, holds onto Tuesday’s losses near 96.60. USD/CAD forms a Head and Shoulder chart pattern, which indicates a bearish reversal. The neckline of the above-mentioned chart pattern is plotted near 1.3715. The near-term trend of the pair remains bearish as it stays below the 20-day Exponential Moving Average (EMA), which trades around 1.3800. The 14-day Relative Strength Index (RSI) slides to near 40.00. A fresh bearish momentum would emerge if the RSI falls below that level. Going forward, the asset could slide towards the round level of…
Share
BitcoinEthereumNews2025/09/18 01:23